Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro

International Journal of Developmental Biology

Volumn 52, Issue 4, 2008, Pages 323-332

  Hargus, Gunnar ^a,d   Kist, Ralf ^b,c,e   Kramer, Jan ^a   Gerstel, Daniela ^a   Neitz, Angela ^a   Scherer, Gerd ^b   Rohwedel, Jürgen ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e INSTITUTE OF HUMAN GENETICS   (United Kingdom)

Author keywords

Chondrogenesis; In vitro differentiation; Mesenchymal condensations; Sox9

Indexed keywords

TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX8;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE MUTATION; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARTILAGE; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; CLONE CELLS; COLLAGEN TYPE II; DNA; EMBRYONIC STEM CELLS; EXONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; HIGH MOBILITY GROUP PROTEINS; MICE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

MUS;

EID: 44849141765     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.072490gh     Document Type: Article

References (44)

1. AIGNER, T., GEBHARD, P.M., SCHMID, E., BAU, B., HARLEY, V. and POSCHL, E. (2003). SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol. 22: 363-372.
2. AKIYAMA, H., CHABOISSIER, M.C., MARTIN, J.F., SCHEDL, A. and DE CROMBRUGGHE, B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16: 2813-2828.
3. ARSENIAN, S., WEINHOLD, B., OELGESCHLAGER, M., RUTHER, U. and NORDHEIM, A. (1998). Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17: 6289-6299.
4. BELL, D.M., LEUNG, K.K., WHEATLEY, S.C., NG, L.J., ZHOU, S., LING, K.W., SHAM, M.H., KOOPMAN, P., TAM, P.P. and CHEAH, K.S. (1997). SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16: 174-178.
5. BI, W., DENG, J.M., ZHANG, Z., BEHRINGER, R.R. and DE CROMBRUGGHE, B. (1999). Sox9 is required for cartilage formation. Nat. Genet. 22: 85-89.
6. BI, W., HUANG, W., WHITWORTH, D.J., DENG, J.M., ZHANG, Z., BEHRINGER, R.R. and DE CROMBRUGGHE, B. (2001). Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A 98: 6698-6703.
7. BOWLES, J., SCHEPERS, G. and KOOPMAN, P. (2000). Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev. Biol. 227: 239-255.
8. BRIDGEWATER, L.C., LEFEBVRE, V. and DE CROMBRUGGHE, B. (1998). Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273: 14998-15006.
9. BROWN, D., WAGNER, D., LI, X., RICHARDSON, J.A. and OLSON, E.N. (1999). Dual role of the basic helix-loop-helix transcription factor scleraxis in mesoderm formation and chondrogenesis during mouse embryogenesis. Development 126: 4317-4329.
10. CSERJESI, P., BROWN, D., LIGON, K.L., LYONS, G.E., COPELAND, N.G., GILBERT, D.J., JENKINS, N.A. and OLSON, E.N. (1995). Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 121: 1099-1110.
11. DE CROMBRUGGHE, B., LEFEBVRE, V. and NAKASHIMA, K. (2001). Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol. 13: 721-727.
12. DELISE, A.M., FISCHER, L. and TUAN, R.S. (2000). Cellular interactions and signaling in cartilage development. Osteoarthritis. Cartilage. 8: 309-334.
13. FOSTER, J.W., DOMINGUEZ-STEGLICH, M.A., GUIOLI, S., KOWK, G., WELLER, P.A., STEVANOVIC, M., WEISSENBACH, J., MANSOUR, S., YOUNG, I.D., GOODFELLOW, P.N. and SCHAFER, A.J. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372: 525-530.
14. HEGERT, C., KRAMER, J., HARGUS, G., MÜLLER, J., GUAN, K., WOBUS, A.M., MÜLLER, P.K. and ROHWEDEL, J. (2002). Differentiation plasticity of chondrocytes derived from mouse embryonic stem cells. J. Cell Sci. 115: 4617-4628.
15. HOUSTON, C.S., OPITZ, J.M., SPRANGER, J.W., MACPHERSON, R.I., REED, M.H., GILBERT, E.F., HERRMANN, J. and SCHINZEL, A. (1983). The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al. in 1971. Am. J. Med. Genet. 15: 3-28.
16. HUANG, W., CHUNG, U.I., KRONENBERG, H.M. and DE CROMBRUGGHE, B. (2001). The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc. Natl. Acad. Sci. USA 98: 160-165.
17. KIST, R., SCHREWE, H., BALLING, R. and SCHERER, G. (2002). Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis. 32: 121-123.
18. KRAMER, J., HEGERT, C., GUAN, K., WOBUS, A.M., MÜLLER, P.K. and ROHWEDEL, J. (2000). Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev. 92: 193-205.
19. KRAMER, J., KLINGER, M., KRUSE, C., FAZA, M., HARGUS, G. and ROHWEDEL, J. (2005). Ultrastructural analysis of mouse embryonic stem cell-derived chondrocytes. Anat. Embryol. (Berl). 210: 175-185.
20. KUHN, R., RAJEWSKY, K. and MÜLLER, W. (1991). Generation and analysis of interleukin-4 deficient mice. Science 254: 707-710.
21. LANSKE, B., KARAPLIS, A.C., LEE, K., LUZ, A., VORTKAMP, A., PIRRO, A., KARPERIEN, M., DEFIZE, L.H., HO, C., MULLIGAN, R.C., ABOU-SAMRA, A.B., JUPPNER, H., SEGRE, G.V. and KRONENBERG, H.M. (1996). PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273: 663-666.
22. LEFEBVRE, L., DIONNE, N., KARASKOVA, J., SQUIRE, J.A. and NAGY, A. (2001). Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity. Nat. Genet. 27: 257-258.
23. LEFEBVRE, V., HUANG, W., HARLEY, V.R., GOODFELLOW, P.N. and DE CROMBRUGGHE, B. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol. 17: 2336-2346.
24. LEFEBVRE, V., LI, P. and DE CROMBRUGGHE, B. (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17: 5718-5733.
25. LEFEBVRE, V., ZHOU, G., MUKHOPADHYAY, K., SMITH, C.N., ZHANG, Z., EBERSPAECHER, H., ZHOU, X., SINHA, S., MAITY, S.N. and DE CROMBRUGGHE, B. (1996). An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell Biol. 16: 4512-4523.
26. MANSOUR, S., HALL, C.M., PEMBREY, M.E. and YOUNG, I.D. (1995). A clinical and genetic study of campomelic dysplasia. J. Med. Genet. 32: 415-420.
27. MATISE, M. P., AUERBACH, W., and JOYNER, A. L. 2000. Production of Targeted Embryonic Stem Cell Clones. In Gene Targeting: A Practical Approach(JOYNER, A. L., ed.). Oxford University Press, Oxford, pp.101-132.
28. METSÄRANTA, M., TOMAN, D., DE CROMBRUGGHE, B. and VUORIO, E. (1991). Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J. Biol. Chem. 266: 16862-16869.
29. MOFTAH, M.Z., DOWNIE, S.A., BRONSTEIN, N.B., MEZENTSEVA, N., PU, J., MAHER, P.A. and NEWMAN, S.A. (2002). Ectodermal FGFs induce perinodular inhibition of limb chondrogenesis in vitro and in vivo via FGF receptor 2. Dev. Biol. 249: 270-282.
30. MORTENSEN, R.M., CONNER, D.A., CHAO, S., GEISTERFER-LOWRANCE, A.A. and SEIDMAN, J.G. (1992). Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell Biol. 12: 2391-2395.
31. NG, L.J., WHEATLEY, S., MUSCAT, G.E., CONWAY-CAMPBELL, J., BOWLES, J., WRIGHT, E., BELL, D.M., TAM, P.P., CHEAH, K.S. and KOOPMAN, P. (1997). SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183: 108-121.
32. OBERLENDER, S.A. and TUAN, R.S. (1994). Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120: 177-187.
33. PERL, A.K., KIST, R., SHAN, Z., SCHERER, G. and WHITSETT, J.A. (2005). Normal lung development and function after Sox9 inactivation in the respiratory epithelium. Genesis. 41: 23-32.
34. SEKIYA, I., TSUJI, K., KOOPMAN, P., WATANABE, H., YAMADA, Y., SHINOMIYA, K., NIFUJI, A. and NODA, M. (2000). SOX9 enhances aggrecan gene promoter/enhancer activity and is up- regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275: 10738-10744.
35. SÜDBECK, P., SCHMITZ, M.L., BAEUERLE, P.A. and SCHERER, G. (1996). Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat. Genet. 13: 230-232.
36. TANIGUCHI, M., SANBO, M., WATANABE, S., NARUSE, I., MISHINA, M. and YAGI, T. (1998). Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. Nucleic Acids Res. 26: 679-680.
37. WAGNER, T., WIRTH, J., MEYER, J., ZABEL, B., HELD, M., ZIMMER, J., PASANTES, J., BRICARELLI, F.D., KEUTEL, J., HUSTERT, E., WOLF, U., TOMMERUP, N., SCHEMPP, W. and SCHERER, G. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-1120.
38. WEGNER, M. (1999). From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27: 1409-1420.
39. WEINHOLD, B., SCHRATT, G., ARSENIAN, S., BERGER, J., KAMINO, K., SCHWARZ, H., RUTHER, U. and NORDHEIM, A. (2000). Srf(-/-) ES cells display non-cell-autonomous impairment in mesodermal differentiation. EMBO J. 19: 5835-5844.
40. WRIGHT, E., HARGRAVE, M.R., CHRISTIANSEN, J., COOPER, L., KUN, J., EVANS, T., GANGADHARAN, U., GREENFIELD, A. and KOOPMAN, P. (1995). The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9: 15-20.
41. YAN, Y.L., MILLER, C.T., NISSEN, R.M., SINGER, A., LIU, D., KIRN, A., DRAPER, B., WILLOUGHBY, J., MORCOS, P.A., AMSTERDAM, A., CHUNG, B.C., WESTERFIELD, M., HAFFTER, P., HOPKINS, N., KIMMEL, C., POSTLETHWAIT, J.H. and NISSEN, R. (2002). A zebrafish sox9 gene required for cartilage morphogenesis. Development 129: 5065-5079.
42. ZANETTI, N.C. and SOLURSH, M. (1986). Epithelial effects on limb chondrogenesis involve extracellular matrix and cell shape. Dev. Biol. 113: 110-118.
43. ZHAO, Q., EBERSPAECHER, H., LEFEBVRE, V. and DE CROMBRUGGHE, B. (1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209: 377-386.
44. ZHOU, G., LEFEBVRE, V., ZHANG, Z., EBERSPAECHER, H. and DE CROMBRUGGHE, B. (1998). Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 273: 14989-14997.